Comparison between single-agent chemotherapy in low-risk gestational trophoblastic neoplasia

Bibliographic Details
Title: Comparison between single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
Authors: Leila Mousavi Seresht, Marjaneh Farazestanian, Zohreh Yousefi
Source: Caspian Journal of Internal Medicine, Vol 14, Iss 1, Pp 108-111 (2023)
Publisher Information: Babol University of Medical Sciences, 2023.
Publication Year: 2023
Collection: LCC:Internal medicine
Subject Terms: actinomycin, gestational trophoblastic neoplasia, methotrexate, outcome, single-agent chemotherapy., Internal medicine, RC31-1245
More Details: Background: Low-risk gestational trophoblastic neoplasia could be cured in the case of appropriate management with single-agent chemotherapy. This study was carried out to compare the efficacy of single-dose methotrexate versus Actinomycin-D in low-risk gestational trophoblastic neoplasia to analyze the most effective agent. Methods: This retrospective cohort study was conducted on the medical record of 170 cases with the diagnosis of low-risk gestational trophoblastic neoplasia from 2012 to 2019 to evaluate the response rate of single-dose weekly-methotrexate versus biweekly-Actinomycin-D. Results: Single agent chemotherapy was required in 170 patients with final risk score of less than 7. Among the 100 cases under weekly-methotrexate therapy, 29 patients were required second-line chemotherapy with Actinomycin-D and combination therapy which means complete remission of 71% with methotrexate, in comparison with 78.5% in the other group. Resistance was mostly seen in patients with documented choriocarcinoma in histology who had not received timely diagnosis and treatment. Conclusion: Individualized decision in the management of low-risk gestational trophoblastic neoplasia cases, based on histology, HCG, and history is the corn stone in successful treatment.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2008-6164
2008-6172
Relation: http://caspjim.com/article-1-3287-en.html; https://doaj.org/toc/2008-6164; https://doaj.org/toc/2008-6172
Access URL: https://doaj.org/article/041c43485ae342abad151329e092996e
Accession Number: edsdoj.041c43485ae342abad151329e092996e
Database: Directory of Open Access Journals
More Details
ISSN:20086164
20086172
Published in:Caspian Journal of Internal Medicine
Language:English